GW406381 In Patients With Peripheral Nerve Injury
NCT00279032
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperalgesia
Neurodynia
Pain
Trauma
Interventions
DRUG:
GW406381
Sponsor
GlaxoSmithKline